PATENT CLAIM ANALYSIS

Application Number: 15741639
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "407000"]

Abstract:
An indole derivative as expressed by Formula (I), a preparation method thereof, a pharmaceutical salt, and use thereof as a therapeutic agent, especially as a FGFR inhibitor. Each substituent in Formula (I) has identical definition as specified in the specification.

Claim (Index 25):
A method for treating cancer comprising administrating a patient in need of treatment an effective amount of the compound according to  claim 1  or a stereoisomer, a tautomer thereof or a pharmaceutically acceptable salt thereof, or the pharmaceutical composition according to  claim 21 , wherein said cancer is selected from lung cancer, gastric cancer, multiple myeloma, bladder cancer or liver cancer, preferably small cell lung cancer, gastric cancer, multiple myeloma, bladder cancer, more preferably gastric cancer.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.47059
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15303704', '16328128', '15766692', '16302310', '14365497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8176973159123498
- 35 USC 102 Novelty (BERT): 0.5508589991571597
- Combined Prediction Score: 0.7910134842368308
- Mean Citation Score: 436.424042
- Max Citation Score: 462.15756
- Similarity Product: 286.0767223035336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test